Ertenli, İhsanKaradağ, ÖmerPehlivan, YavuzDalkılıç, EdizOnat, Ahmet MesutKısacık, BünyaminCan, GerçekAkar, ServetÇapar, SedatKalyoncu, ÜmutÖksüz, Mustafa FerhatTarhan, Emine FigenAkkoç, Nurullah2024-08-012024-08-012015-10-012326-5191https://hdl.handle.net/11452/43604Bu çalışma, 06-11, Kasım 2015 tarihlerinde San Francisco[Amerika]’da düzenlenen Annual Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessRheumatologyThe effect of rheumatoid factor and anti-cyclic citrullinated peptide positivity on drug survival of abatacept in patients with rheumatoid arthritis in routine care: The results from turkbio registryMeeting Abstract00037086020145467Supplement 10